atorvastatin has been researched along with 24-hydroxycholesterol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laaksonen, R; Lehtimäki, T; Lütjohann, D; Päivä, H; Thelen, KM | 1 |
| Gao, X; Gu, Y; Li, J; Qin, J; Sun, C; Xiao, L; Yang, H; Yang, R; Yang, Y; Ye, J; Yuan, Y; Zhang, F; Zhang, J; Zhang, L; Zhao, Y | 1 |
2 other study(ies) available for atorvastatin and 24-hydroxycholesterol
| Article | Year |
|---|---|
High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels.
Topics: Adult; Aged; Atorvastatin; Biomarkers; Brain; Cholesterol; Female; Heptanoic Acids; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin | 2006 |
Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma.
Topics: Animals; Astrocytes; Atorvastatin; Brain; Brain Neoplasms; Cell Line, Tumor; Gene Knock-In Techniques; Glioma; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isocitrate Dehydrogenase; Mice; Mice, Transgenic; Mutation; Myelin Sheath; Primary Cell Culture | 2020 |